Progress in cancer treatment procedures, with it, has brought challenges that go beyond cure. Toxicity and morbidity are among the biggest hurdles that a cancer patient has to face while undergoing chemotherapy or radiation therapy.

New York, NY -- (SBWire) -- 01/14/2016 --The growing incidence of cancer around the world is largely responsible for the growth of the global cancer supportive care products market. A wide range of drugs available in the market today help in preventing side-effects of cancer treatment, and a surge in cancer incidence increases the adoption rate of cancer supportive care products. Here are a few key facts about cancer based data published by some of the leading cancer and health organizations:

Request sample of this report: http://www.persistencemarketresearch.com/samples/5336

According to the World Health Organization,

In 2012, an estimated 8.2 million cancer-related deaths and approximately 14 million new cancer cases were reported

Over the next two decades, the number of new cancer cases is projected to rise by 70.0%

Over 60.0% of the world's total new annual cancer cases occur in Asia, Africa, and South and Central America

The most common causes of cancer deaths are cancers of lung – 1.5 mn; liver – 745,000; stomach – 723,000; colorectal – 694,000; and breast – 521,000.

According to the United States National Cancer Institute,

An estimated 589,430 cancer-related deaths and 1,658,370 new cases of cancer will be reported in 2015 in the United States alone

In 2014, an estimated 1,960 children and adolescents between the ages of 0 and 19 died from cancer while 15,780 were diagnosed with the disease

The rate of cancer mortality in the country is 171.2 per 100,000 women and men per year while the rate of cancer incidence is 454.8 per 100,000 women and men in a year

An estimated 39.60% women and men in the US will be diagnosed with cancer at some point during their lifetime.

Focus on Innovation Key Factor Driving the Market

There are a number of players competing in the global cancer supportive care products market: Hoffmann-La Roche Ltd., Fagron Group BV, Johnson & Johnson Private Ltd., Baxter International Inc., Novartis AG, Amgen Inc., and Teva Pharmaceutical Industries Ltd. These companies have been emphasizing on innovation and the development of new drugs, therapeutic approaches, and treatment options so as to gain a competitive edge over the rest. For instance, in the last two years alone, 21 new molecular entities for the treatment of advanced cancer have been launched, leading to additional combinations and lines of therapies. Strong research activities by these players form a key factor driving the global cancer supportive care products market.

North America Most Lucrative Market for Cancer Supportive Care Products

Driven by an increase in healthcare spending and alarming rise in cancer incidence, the global cancer supportive care products market is anticipated to register a modest CAGR of 4.30% from 2015 to 2021, increasing from a value of US$23.6 bn in 2014 to US$31.7 bn by 2021.

View Detail Report: http://www.persistencemarketresearch.com/market-research/cancer-supportive-care-products-market.asp

Even though the US market in North America is anticipated to register single-digit growth, it is projected to be the most lucrative cancer supportive care products market in terms of value fueled by the rising number of government initiatives to increase adherence and improve access to various drugs, higher healthcare spending, and strong direct-to-consumer marketing. However, cost issues are likely to restrict the growth of this market, but not to a great extent.

About Persistence Market Research (PMR)
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.